Northwire Canada EditionFriday, July 17, 2026
Sign inSubscribe
Northwire
⌕
ALS 57.46 +0.0% WGX 4.43 +0.0% LIFT 3.15 +0.0% NTR 94.27 +0.0% ICON 0.045 +0.0% LMG 0.450 +0.0% NZP 0.050 +0.0% RJX 0.030 +0.0% PRU 4.64 +0.0% MOO 0.720 +0.0% BSX 0.950 +0.0% SLI 3.08 +0.0% LUN 33.59 +0.0% LALI 0.055 +0.0% SCD 0.170 +0.0% HWY 0.370 +0.0% ALS 57.46 +0.0% WGX 4.43 +0.0% LIFT 3.15 +0.0% NTR 94.27 +0.0% ICON 0.045 +0.0% LMG 0.450 +0.0% NZP 0.050 +0.0% RJX 0.030 +0.0% PRU 4.64 +0.0% MOO 0.720 +0.0% BSX 0.950 +0.0% SLI 3.08 +0.0% LUN 33.59 +0.0% LALI 0.055 +0.0% SCD 0.170 +0.0% HWY 0.370 +0.0%

Healthcare

Page 100
  1. Nov 18, 2025 · 11:43 · MSCL

    Satellos research published in Nature Comms

    Satellos research published in Nature Comms

    01
  2. Nov 18, 2025 · 11:19 · FNDX

    Fendx signs MOU with Aquaox on green pathogen agents

    Fendx signs MOU with Aquaox on green pathogen agents

    02
  3. Nov 18, 2025 · 08:31 · DTR

    DiagnosTear Technologies Inc. Announces Closing of Private Placement of Units

    DiagnosTear Technologies Inc. Announces Closing of Private Placement of Units

    03
  4. Nov 18, 2025 · 08:30 · FRX

    Fennec Pharmaceuticals Announces Closing of Private Offering of Common Shares in Canada

    Fennec Pharmaceuticals Announces Closing of Private Offering of Common Shares in Canada

    04
  5. Nov 18, 2025 · 08:30 · AIAI

    NetraMark Signs Four New Contracts With a Leading Global Pharmaceutical Company To Enhance Clinical Trial Insights

    NetraMark Signs Four New Contracts With a Leading Global Pharmaceutical Company To Enhance Clinical Trial Insights

    05
  6. Nov 18, 2025 · 07:15 · ASG

    Aurora Spine Corporation Announces Record Third Quarter Financial Results

    Aurora Spine Corporation Announces Record Third Quarter Financial Results

    06
  7. Nov 18, 2025 · 07:01 · VIVI

    TempraMed Announces Frankfurt Stock Exchange Listing and Corporate Awareness Agreement

    TempraMed Announces Frankfurt Stock Exchange Listing and Corporate Awareness Agreement

    07
  8. Nov 18, 2025 · 07:00 · LSL

    LSL PHARMA GROUP COMPLETES THE ACQUISITION OF LABORATOIRE DU-VAR INC.

    LSL PHARMA GROUP COMPLETES THE ACQUISITION OF LABORATOIRE DU-VAR INC.

    08
  9. Nov 18, 2025 · 07:00 · ALGO

    Light AI Version 1.0 Software Completion

    Light AI Version 1.0 Software Completion

    09
  10. Nov 18, 2025 · 07:00 · HLS

    Esperion Partner HLS Therapeutics Announces Approval of NILEMDO(TM) for the Reduction of LDL-Cholesterol in Canadians at Risk of Cardiovascular Disease

    Esperion Partner HLS Therapeutics Announces Approval of NILEMDO(TM) for the Reduction of LDL-Cholesterol in Canadians at Risk of Cardiovascular Disease

    10
  11. Nov 18, 2025 · 07:00 · MSCL

    Satellos Announces Publication in Nature Communications Supporting its Novel Treatment Approach for Duchenne Muscular Dystrophy

    Satellos Announces Publication in Nature Communications Supporting its Novel Treatment Approach for Duchenne Muscular Dystrophy

    11
  12. Nov 18, 2025 · 06:31 · FNDX

    FendX and Aquaox Sign MOU to Pursue Innovation in Sustainable Pathogen Elimination

    FendX and Aquaox Sign MOU to Pursue Innovation in Sustainable Pathogen Elimination

    12
  13. Nov 17, 2025 · 19:28 · SEGN

    Seegnal appoints Bibi-Aviv as CEO

    Seegnal appoints Bibi-Aviv as CEO

    13
  14. Nov 17, 2025 · 18:35 · MDP

    Medexus obtains $51-million (U.S.) credit, plans NCIB

    Medexus obtains $51-million (U.S.) credit, plans NCIB

    14
← Newer Older →